Congenital histiocytosis with central nervous system involvement and a novel PTPRJ::RASGRF1 fusion
Publication date
2026-06
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
Histiocytic neoplasms are rare diseases characterized by clonal expansions of cells with a macrophage or dendritic cell phenotype. They are driven by mutations activating the MAPK pathway and may involve diverse organs, including the central nervous system (CNS). We describe a newborn with congenital histiocytosis affecting the CNS, skin, lungs, lymph nodes, thyroid, fingernail, and soft tissues – including a tumor originating from the tongue obstructing the upper airway. Histopathology revealed an atypical histiocytosis with strong CD1a and variable Langerin expression; post-mortem transcriptome sequencing identified a novel PTPRJ::RASGRF1 fusion. This case expands the molecular landscape of histiocytic neoplasms, highlighting the value of comprehensive genomic profiling.
Keywords
Brain, CNS, ERK, Histiocytic neoplasm, Indeterminate dendritic cell histiocytosis, Langerhans cell histiocytosis, MAPK, Dentistry (miscellaneous), Biochemistry, Genetics and Molecular Biology (miscellaneous), Hematology, Oncology, Radiology Nuclear Medicine and imaging
Citation
Kemps, P G, Bugiani, M, Scheijde-Vermeulen, M A, Koudijs, M J, Emile, J F, Berkhemer, O A, Onland, W & Bos, C V D 2026, 'Congenital histiocytosis with central nervous system involvement and a novel PTPRJ::RASGRF1 fusion', EJC Paediatric Oncology, vol. 7, 100492. https://doi.org/10.1016/j.ejcped.2026.100492